BioRestorative Financial Statements From 2010 to 2025

Stocks USA . 
Stock . BioRestorative Therapies
BRTX Stock  USD 2.29  0.17  6.91%   
BioRestorative Therapies financial statements provide useful quarterly and yearly information to potential BioRestorative Therapies investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on BioRestorative Therapies financial statements helps investors assess BioRestorative Therapies' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting BioRestorative Therapies' valuation are summarized below:
Gross Profit
352.3 K
Market Capitalization
15.8 M
Enterprise Value Revenue
7.4672
Revenue
377 K
Earnings Share
(2.38)
We have found one hundred twenty available fundamental signals for BioRestorative Therapies, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of BioRestorative Therapies prevailing market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 5.4 M in 2025. Enterprise Value is likely to drop to about 4.5 M in 2025

BioRestorative Therapies Total Revenue

120,304

Check BioRestorative Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioRestorative Therapies' main balance sheet or income statement drivers, such as Interest Expense of 12.7 K, Selling General Administrative of 7.7 M or Depreciation And Amortization of 178.1 K, as well as many indicators such as Price To Sales Ratio of 54.99, Dividend Yield of 0.0 or PTB Ratio of 0.69. BioRestorative financial statements analysis is a perfect complement when working with BioRestorative Therapies Valuation or Volatility modules.
  
Check out the analysis of BioRestorative Therapies Correlation against competitors.
For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.

BioRestorative Therapies Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets15.2 M14.5 M6.6 M
Slightly volatile
Other Current Liabilities1.7 M2.3 M1.6 M
Slightly volatile
Total Current Liabilities3.7 M2.3 M4.8 M
Pretty Stable
Accounts Payable161.9 K170.4 K974.8 K
Slightly volatile
Other Current Assets368.6 K351 K137.4 K
Slightly volatile
Total Liabilities4.3 M2.3 M5.6 M
Pretty Stable
Intangible Assets946.2 K642.3 K1.2 M
Slightly volatile
Common Stock403424137.1 K
Slightly volatile
Property Plant Equipment351.7 K578.2 K341.5 K
Slightly volatile
Short and Long Term Debt Total138.8 K146.1 K2.8 M
Slightly volatile
Property Plant And Equipment Net429.2 K583.6 K397.4 K
Slightly volatile
Cash966.2 K1 M1.9 M
Slightly volatile
Non Current Assets Total1.3 M1.4 M1.2 M
Slightly volatile
Long Term Debt208.7 K219.7 K1.2 M
Pretty Stable
Cash And Short Term Investments13.4 M12.7 M4.8 M
Slightly volatile
Common Stock Shares Outstanding5.1 M4.9 M1.2 M
Slightly volatile
Liabilities And Stockholders Equity15.2 M14.5 M6.2 M
Slightly volatile
Non Current Liabilities Total177.3 K186.7 K1 M
Slightly volatile
Other Stockholder Equity189.2 M180.2 M74.6 M
Slightly volatile
Total Current Assets13.8 M13.1 M5 M
Slightly volatile
Short Term Debt138.8 K146.1 K2.1 M
Slightly volatile
Current Deferred Revenue1.091.151.1 M
Very volatile
Other Assets794.9 K757 K319.7 K
Slightly volatile
Inventory0.860.93.6 K
Slightly volatile
Other Liabilities109.4 K62.8 K72.8 K
Very volatile
Short and Long Term Debt50.4 K53.1 K2.9 M
Slightly volatile
Net Receivables22 K17.4 K47.6 K
Slightly volatile
Capital Stock17 K17.9 K30.1 K
Pretty Stable
Capital Lease Obligations370.3 K271.5 K516.3 K
Slightly volatile
Property Plant And Equipment Gross1.1 M1.3 M1.4 M
Slightly volatile
Common Stock Total Equity229 K257.6 K280.9 K
Slightly volatile
Long Term Debt Total3.4 M3.8 M4.2 M
Slightly volatile
Capital Surpluse70.6 M79.4 M86.6 M
Slightly volatile

BioRestorative Therapies Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative7.7 M12.8 M7.4 M
Slightly volatile
Depreciation And Amortization178.1 K190.6 K164.5 K
Slightly volatile
Selling And Marketing Expenses154.9 K193.2 K145 K
Pretty Stable
Other Operating Expenses10.3 M17.7 M9.6 M
Slightly volatile
Research Development4.9 M4.6 M2 M
Slightly volatile
Total Operating Expenses10.3 M17.7 M9.5 M
Slightly volatile
Total Revenue120.3 K131.2 K130.7 K
Very volatile
Reconciled Depreciation137.5 K139.3 K205.9 K
Slightly volatile

BioRestorative Therapies Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditures146.7 K153.9 K188.4 K
Pretty Stable
Total Cash From Financing Activities2.6 M2.7 M5.8 M
Slightly volatile
End Period Cash Flow2 M1 M1.9 M
Slightly volatile
Stock Based Compensation5.1 M9 M4.7 M
Slightly volatile
Begin Period Cash Flow2.1 M2 M1.9 M
Slightly volatile
Depreciation167.4 K190.6 K154.7 K
Slightly volatile
Net Borrowings273.1 K287.5 K1.4 M
Very volatile
Change To Netincome8.8 M14.4 M7.1 M
Slightly volatile
Issuance Of Capital Stock4.7 M2.6 M2.1 M
Slightly volatile
Change Receivables12 K13.5 K14.7 K
Slightly volatile
Cash And Cash Equivalents Changes2.9 M3.2 M3.5 M
Slightly volatile
Cash Flows Other Operating3.6 M4.1 M4.4 M
Slightly volatile
Dividends Paid455.3 K512.2 K558.4 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio54.9957.88711
Slightly volatile
Average Payables154 K162.1 K820.5 K
Slightly volatile
Stock Based Compensation To Revenue58.3261.39112
Pretty Stable
Capex To Depreciation1.891.191.6135
Pretty Stable
Inventory Turnover10498.9581.4106
Slightly volatile
Days Of Inventory On Hand0.00140.00152.6 K
Slightly volatile
Payables Turnover1.551.481.4294
Slightly volatile
Sales General And Administrative To Revenue83.6588.06255
Slightly volatile
Average Inventory0.550.573.9 K
Slightly volatile
Research And Ddevelopement To Revenue30.2331.8282.1734
Pretty Stable
Capex To Revenue1.281.3513.449
Slightly volatile
Cash Per Share2.873.02135
Slightly volatile
Days Payables Outstanding243256691.1 K
Pretty Stable
Income Quality0.470.710.4479
Very volatile
Intangibles To Total Assets0.06180.06510.3496
Slightly volatile
Current Ratio5.783.936.9218
Slightly volatile
Graham Number12.5413.236.4 K
Slightly volatile
Capex Per Share0.04430.0466422
Slightly volatile
Revenue Per Share0.03780.0398134
Slightly volatile
Interest Debt Per Share0.0420.04436.3 K
Slightly volatile
Debt To Assets0.01410.01482.5193
Slightly volatile
Operating Cycle52.7955.562.3 K
Slightly volatile
Days Of Payables Outstanding243256691.1 K
Pretty Stable
Ebt Per Ebit1.140.621.3538
Very volatile
Quick Ratio5.783.936.9213
Slightly volatile
Net Income Per E B T1.091.121.1214
Slightly volatile
Cash Ratio0.290.314.1031
Pretty Stable
Days Of Inventory Outstanding0.00140.00152.6 K
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.171.181.0697
Very volatile
Fixed Asset Turnover0.370.330.3313
Pretty Stable
Debt Ratio0.01410.01482.5193
Slightly volatile
Price Sales Ratio54.9957.88711
Slightly volatile
Asset Turnover0.01260.01330.0569
Pretty Stable

BioRestorative Therapies Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap5.4 M6.6 M2.9 M
Slightly volatile

BioRestorative Fundamental Market Drivers

Cash And Short Term Investments11.1 M

BioRestorative Upcoming Events

12th of February 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
12th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About BioRestorative Therapies Financial Statements

BioRestorative Therapies investors use historical fundamental indicators, such as BioRestorative Therapies' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioRestorative Therapies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue 1.15  1.09 
Total Revenue131.2 K120.3 K
Cost Of Revenue190.6 K124.1 K
Stock Based Compensation To Revenue 61.39  58.32 
Sales General And Administrative To Revenue 88.06  83.65 
Research And Ddevelopement To Revenue 31.82  30.23 
Capex To Revenue 1.35  1.28 
Revenue Per Share 0.04  0.04 
Ebit Per Revenue(93.96)(98.65)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CSXCSX Corporation
ETONEton Pharmaceuticals
ALLTAllot Communications

Additional Tools for BioRestorative Stock Analysis

When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY